Global B2B Pharmaceutical Marketplace · Sourcing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Sevelamer Carbonate 800 mg  Tablets bulk supplier for pharma manufacturers

Sevelamer Carbonate 800 Mg Tablets 400 mg , 800mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 400 mg , 800mg

Reference Brands: Renvela (USA)

Category: Nephrology

Sevelamer Carbonate Tablets are non-calcium phosphate binders used in nephrology to manage high phosphate levels in CKD patients on dialysis.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Product Description:

Sevelamer Carbonate Tablets are a leading phosphate binder used to control hyperphosphatemia in chronic kidney disease (CKD) patients undergoing dialysis. Unlike calcium-based binders, Sevelamer carbonate reduces serum phosphate levels without increasing calcium load, minimizing the risk of vascular calcification. It is widely prescribed in nephrology for effective phosphate management in ESRD (end-stage renal disease). Marketed under the brand name Renvela® in the US and EU, Sevelamer Carbonate Tablets are essential for renal care protocols. We offer high-quality, GMP-compliant bulk supply for global Pharma B2B procurement, ideal for hospital tenders, dialysis centers, and private label pharmaceutical companies.

Sevelamer Carbonate 800 Mg Tablets — third party manufacturing & bulk supply

Sevelamer Carbonate 800 Mg Tablets 400 mg , 800mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Sevelamer Carbonate 800 Mg Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Sevelamer Carbonate 800 Mg Tablets →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Sevelamer carbonate is used to control high blood phosphate levels (hyperphosphatemia) in patients with chronic kidney disease, especially those undergoing dialysis. It helps prevent complications such as bone disorders and cardiovascular issues associated with elevated phosphate.

Sevelamer carbonate is a non-absorbed, polymeric amine compound that binds phosphate in the gastrointestinal tract, reducing its absorption into the bloodstream. Unlike sevelamer hydrochloride, it contains carbonate instead of chloride, which can help maintain acid-base balance.

Sevelamer carbonate is marketed under the trade name Renvela.

Renvela is marketed by Sanofi, with additional generic versions produced by multiple pharmaceutical manufacturers worldwide.

The generic name is sevelamer carbonate.

The primary brand name is Renvela.

Sevelamer carbonate is manufactured in multiple countries, including the USA, EU nations, and other regulated markets, by approved pharmaceutical manufacturers following international quality and safety standards.

Related Products

Atrasentan Hydrochloride

Strength:
0.75 mg, 1.25 mg, 10 mg

Form: Tablets

Reference Brands: Xinlay (USA/EU), Vanrafia (USA/LATAM)

View Details
Tiopronin

Strength:
100 mg, 200 mg , 300 mg

Form: Tablets, Capsules

Reference Brands: Thiola (USA), Mercaptamine (EU)

View Details
Nedosiran

Strength:
80 mg, 160 mg

Form: Injection

Reference Brands: Ryplazim (USA)

View Details
Probenecid

Strength:
500 mg

Form: Tablets

Reference Brands: Benemid (USA)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.